Dear Editor, Early mammalian embryogenesis begins with a fertilized egg and zygotic genome activation (ZGA), the switch from maternal to zygotic control. In mouse two-cell (2C) embryos, ZGA is characterized by the transient activation of murine endogenous retrovirus-L (MERVL) and 2C-specific genes, such as Zscan4 1. As development proceeds, expression of these genes declines as cells transition from a totipotent state, capable of producing all lineages, including extra-embryonic tissues, to a pluripotent state restricted to the three germ layers. Totipotency and pluripotency are dynamic cellular states central to development and hold great promise for both fundamental research and clinical applications in regenerative medicine 1. Embryonic stem cells (ESCs) derived from the inner cell mass of blastocysts exhibit pluripotency, and a rare subpopulation termed two-cell-like cells (2CLCs) spontaneously emerges, recapitulating key molecular features and developmental potentials of 2C-stage embryos 2. The molecular mechanisms governing ZGA and the transitions between pluripotency and totipotency have been increasingly elucidated across multiple regulatory layers, particularly at the transcriptional, epigenetic, and metabolic levels 1,3,4. Recent studies reported that spliceosomal repression reprograms both human and mouse pluripotent stem cells (PSCs) toward a totipotent state 5 , suggesting an unexpected layer of post-transcriptional regulation. However, the precise post-transcriptional mechanisms governing pluripotency-totipotency transitions remain unclear. RNA-binding proteins (RBPs) mediate post-transcriptional control of mRNA stability, localization, and translation, thereby influencing stem cell fate. Long interspersed nuclear element 1 (LINE1)-type transposase domain containing 1 (L1td1) is the only domesticated protein-coding gene almost entirely derived from the LINE1 (L1) retroelement 6. L1td1 is highly expressed in PSCs and has been reported to be essential for maintaining pluripotency in human cells 7. Intriguingly, evolutionary analyses suggest that L1td1 originated under positive selection in primates and rodents and was later co-opted into pluripotency networks 6. Recent studies further reveal that L1td1 interacts with ancestral L1 ORF1p to facilitate L1 retrotransposition in cancer cells 8. Despite links to transposable elements (TEs) and pluripotency, L1td1's role in totipotency remains unexplored. To investigate the potential role of L1td1 in embryonic development, we analyzed its expression across different developmental stages from single-embryo RNA-seq and proteomic datasets 9,10. L1td1 peaks at the late 2C stage when Zscan4c declines, and rises again in the inner cell mass, a trend also reflected